JRSIS Health Care Corporation
JRSS
$0.0132
-$0.0016-10.81%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 55.92% | 97.36% | 115.85% | -72.80% | -89.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 55.92% | 97.36% | 115.85% | -72.80% | -89.47% |
| Cost of Revenue | 49.69% | 81.64% | 102.42% | 134.40% | 28,763.44% |
| Gross Profit | 104.21% | 261.46% | 268.52% | 2,757.63% | 3,826.88% |
| SG&A Expenses | 118.96% | 40.19% | 7.26% | -25.79% | 14.92% |
| Depreciation & Amortization | -38.35% | -159.15% | -- | -- | -200.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 47.31% | 62.70% | 73.43% | 89.76% | 885.70% |
| Operating Income | 17.57% | 87.29% | 85.81% | 122.70% | -15.50% |
| Income Before Tax | 39.94% | 101.76% | 100.51% | 134.80% | -19.69% |
| Income Tax Expenses | 46.91% | 43.90% | 6.02% | -- | -- |
| Earnings from Continuing Operations | 38.25% | 99.73% | 99.03% | 132.26% | -22.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 203.70% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -14.23% | -53.62% | -43.70% | -81.31% | -- |
| Net Income | -100.52% | -99.85% | 101.41% | 140.89% | 201.61% |
| EBIT | 17.57% | 87.29% | 85.81% | 122.70% | -15.50% |
| EBITDA | 24.89% | 101.97% | 100.69% | 551.57% | -129.58% |
| EPS Basic | -102.97% | -101.35% | 99.98% | 100.01% | 102.27% |
| Normalized Basic EPS | -187.50% | 94.08% | 96.92% | 100.99% | 98.70% |
| EPS Diluted | -102.97% | -101.35% | 99.98% | 100.01% | 102.26% |
| Normalized Diluted EPS | -187.50% | 94.08% | 96.92% | 100.99% | 98.69% |
| Average Basic Shares Outstanding | 17.61% | 36.86% | 65.35% | 112.75% | 3,222.25% |
| Average Diluted Shares Outstanding | 17.61% | 36.86% | 65.35% | 112.73% | 3,212.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |